1. Introduction
1,2-propanediol (PPD) is a common industrial chemical that has been used in the mass production of important commercial products such as biodegradable plastics and polymer resins [
1]. PPD is a naturally occurring three-carbon diol, usually derived from the microbial degradation of renewable resources [
2]. It is abundantly present in the human gut as well [
3]. Many bacteria are capable of growing on PPD [
4,
5]. However, wildtype
E. coli K12 strains cannot utilize PPD as a carbon source for growth (PPD
−), although they harbor the
fucO gene encoding lactaldehyde:propanediol oxidoreductase (hereafter referred to as propanediol oxidoreductase).
The
fucAO operon within the
fuc regulon (
Figure 1) encodes an L-fuculose-1-P aldolase (FucA) and a propanediol oxidoreductase (FucO). The aldolase catalyzes the cleavage of L-fuculose-1-P [(a metabolite from the fucose pathway mediated by three enzymes encoded by the
fucPIK operon: the L-fucose permease (FucP), the L-fucose isomerase (FucI), and the L-fuculose kinase (FucK)], yielding dihydroxyacetone phosphate and L-lactaldehyde. This process is independent of the presence of oxygen.
Under aerobic conditions, L-lactaldehyde is oxidized to L-lactate by aldehyde oxidoreductase (AldA), which is further oxidized to pyruvate by an FAD-dependent dehydrogenase (LldD) prior to entry into central metabolism. The other 3-carbon intermediate, dihydroxyacetone-P, is converted to pyruvate, which feeds into the Krebs (TCA) cycle. However, under anaerobic conditions, L-lactaldehyde (an intermediate metabolite of both the L-fucose and the L-rhamnose catabolic pathways) is reduced to PPD by FucO, and PPD is then excreted from the cell as a waste product [
6,
7]. Conceivably, in the absence of oxygen, only dihydroxyacetone-P can be used as an energy source for growth. If PPD is present, the same PPD oxidoreductase, FucO, enables the oxidation of PPD back to L-lactaldehyde, which can be converted to L-lactate and then pyruvate prior to entry into the TCA cycle. However, wildtype
E. coli strains fail to metabolize PPD because the
fucAO operon is not expressed in the presence of PPD alone. In addition, as an iron (Fe
2+)-dependent metalloenzyme, FucO is sensitive to oxygen [
8,
9].
Expression of the
fucAO operon relies on the Crp-cAMP complex [
10]. As part of the
fuc regulon, the
fucAO operon is regulated by the regulon regulator FucR as well [
11,
12,
13]. FucR is first activated by its cofactor, fuculose-1-phosphate. FucR, with its cofactor binding, promotes transcription of both
fucPIK and
fucAO, and also self-activates. However, to date, the binding sites for Crp and FucR have not been identified within the
fucAO regulatory region [
12]. In addition to Crp and FucR, a recent publication reports that both
fucPIK and
fucAO operons are positively regulated by SrsR, a newly identified transcription factor. SrsR is involved in regulating gene expression, mainly during the stationary growth phase [
14].
When PPD serves as the sole carbon source, the
fucAO operon is not induced since
fucR, encoding FucR, is insufficiently expressed, and no inducer (fuculose-1-phosphate) is synthesized. Although wildtype
E. coli cells are PPD
−, PPD
+ (able to grow on PPD) mutants can readily arise after prolonged incubation with PPD. These PPD
+ mutants carry an IS5 element inserted upstream of the
fucAO promoter region. With this insertion, the
fucAO operon expression is believed to be “constitutive,” while the
fucPIK operon becomes inactive and non-inducible by L-fucose [
13,
15,
16]. However, it is unknown as to the molecular mechanism by which IS5 activates the
fucAO operon or whether any host regulatory proteins are involved in IS5 activation of the operon.
Using a predictive computational method, Huerta and Collado-Vides proposed the presence of a σ
70 promoter (P
fucAO.hc), including a −35 element, a −10 element, and the transcriptional start site (+1), upstream of the
fucA start codon [
17]. This putative promoter has an unusually long (165 bp) untranslated region (5′UTR) between +1 and the
fucA start codon. However, this proposed
fucAO operon promoter has never been experimentally verified. In addition to the operon promoter, the
fucO gene is driven by a second promoter (P
fucO) nested in the 3′ end of
fucA [
18]. It is unknown how and to what extent this promoter contributes to
fucO transcription; it is also unknown if it is inducible by fuculose-1-phosphate like the
fucAO operon promoter.
Here, we first show that the predicted fucAO promoter (PfucAO.hc) is not a true promoter and that the fucO promoter (PfucO) is too weak to cause appreciable induction. Then we identify the actual transcriptional start site (+1) for the main fucAO promoter (PfucAO) (using 5′RACE), which is located at the 63rd nucleotide upstream of the fucA start codon. The fucAO operon is embedded in a chromosomal region that is transcriptionally repressed. The newly identified promoter (PfucAO) is highly induced by growth on fucose, and its activity depends on FucR and Crp but not SrsR, either during the logarithmic or the stationary growth phase. Two Crp binding sites and two FucR binding sites were identified and functionally validated. The upstream Crp binding site is more important for operon expression than the downstream site. The second FucR binding site, which is closer to the promoter and is upstream of the Crp binding site, plays a greater role in activating the operon. Although both Crp and FucR are needed for full activation of fucAO, we speculate that FucR’s primary function is to facilitate Crp binding, which in turn recruits RNA polymerase and thus initiates transcription.
3. Discussion
The fucAO operon encodes two important enzymes: a fuculose aldolase and a propanediol oxidoreductase, both of which are involved in the bacterial utilization of L-fucose and L-1,2-propanediol. Contrary to the fucPIK operon (the other operon within the fuc regulon) and many other sugar metabolic operons in E. coli, the fucAO operon has not been well studied, especially with respect to its transcriptional regulation. We know that its expression relies on the presence of L-fuculose-1-P, the fuc regulon regulator, FucR, and the global activator, Crp. However, little is known as to the actual promoter region and how these regulators activate the fucAO operon. In this work, we identified and confirmed the true primary promoter (PfucAO), driving fucAO operon transcription, while refuting the hypothetical promoter (PfucAO.hc), predicted by a computer program, which has long been used by ecocyc.org. Meanwhile, we found that the fucO promoter nested within the fucA gene is weak and uninducible, thus being unimportant for operon expression. Two Crp-cAMP binding sites and two FucR binding sites were functionally validated. The second FucR binding site and the first Crp binding site (adjacent to each other) are essential for operon expression, while the other two FucR and Crp sites are needed only for maximal operon expression. Furthermore, we provided evidence that the fucAO operon is located within a chromosomal region that is transcriptionally repressed.
Wildtype strains of
E. coli commonly used in laboratories are unable to utilize propanediol for aerobic growth (PPD
−) because the
fucAO operon has long been thought to be “silent” when only PPD is present as a carbon source [
12,
17]. However, using a sensitive transcriptional operon
lacZ reporter, we showed that the operon is expressed at a detectable level (over 16 units of β-galactosidase activity yielded from both P
fucAO and P
fucO) in the absence of fucose in the growth medium (i.e., noninducing conditions). Compared with the silent
bglGFB operon (<1 unit of β-galactosidase activity) [
25,
26,
27], the
fucAO operon is not “silent.” To aerobically grow on PPD, propanediol oxidoreductase (FucO) is needed in large amounts. This iron (Fe
2+)-dependent enzyme is only catalytically active under anaerobic conditions due to the loss of Fe
2+ in the presence of oxygen [
10,
28]. The negative aerobic growth of wildtype cells on PPD may not only result from the low amount of propanediol oxidoreductase synthesized but also from the catalytic inactivation of the enzyme by oxidation. IS5 insertional mutants are capable of aerobic growth on PPD minimal agar plates, probably due to the presence of a large amount of the oxidoreductase, which is still adequate for cellular growth after being partially inactivated by metal-catalyzed oxidation. In addition, it is known that growing bacterial cells on agar plates can readily generate local anaerobic or micro-anaerobic conditions inside the colony [
29,
30]. On the other hand, leaky expression might be physiologically relevant, as the cells are always prepared for the presence of fucose or IS5 insertional activation of the
fucAO operon when PPD is the only carbon source present.
The
fucAO promoter (
Figure 4B), long used by ecocyc.org, was predicted by a computer program [
1]. We showed that this promoter has no activity under either inducing or noninducing conditions (
Figure 3). The first two Crp binding sites (O
Crp0 and O
Crp1) upstream of the predicted promoter are not relevant to
fucAO operon activation (
Figure 6). The other two Crp binding sites (O
Crp2 and O
Crp3), confirmed to be important for Crp activation of the operon as revealed by this study, are unusually located in the 5′UTR of the predicted promoter used in EcoCyc. In addition, the second FucR binding site, O
FucR3, overlaps the -35 element. Based on these features, it appears impossible for Crp and FucR to activate the
fucAO operon by binding to these functionally validated sites, consistent with our conclusion that the predicted promoter indicated in EcoCys is not a true promoter.
In this work, we confirmed that FucR and Crp are strong dominant regulators that activate the
fucAO operon. Meanwhile, our data disprove that SrsR directly regulates the operon in either exponentially growing cells or stationary-phase starving cells. Huerta and Collado-Vides [
1] found a SrsR binding site present in the 5′UTR of the
fucPIK promoter (
Figure 4B). However, the presence of this site had not been functionally verified. If this is a valid SrsR binding site, it is unknown how it can elevate the transcription of the
fuc regulon. Nevertheless, we cannot completely rule out the possibility that SrsR directly or indirectly affects the expression of both or one of the
fucPIK and/or
fucAO operons under certain unknown conditions. In the case that SrsR does enhance the
fucPIK operon expression, it may indirectly impact the
fucAO operon in the presence of fucose since part of
fucR expression is driven by the
fucPIK promoter.
As described above, the
fucAO operon is not “silent,” even in the absence of fucose. In the current study, we showed that this leaky expression is attributed to the presence of Crp, not FucR, since the loss of Crp abolished expression while the loss of FucR had essentially no effect. In the presence of fucose, it is known that fuculose-1-P bound to FucR dramatically elevates operon expression, but our data indicate such an activation is dependent on Crp. When the upstream Crp binding site was mutated, the same activated FucR failed to promote operon expression (
Figure 7), indicating that the presence of Crp bound to P
fucAO is essential for FucR activation of the operon.
Crp regulates at least 180 promoters by binding to one or more 22-bp symmetrical sites with the consensus core half-site TGTGA [
23,
31,
32,
33]. Once bound to DNA, Crp directly recruits RNA polymerase to promoters via the formation of the “Crp-αCTD-DNA complex,” thereby initiating transcription [
34,
35,
36,
37]. Many Crp-dependent promoters are co-regulated by one or more other factors bound to DNA sites near Crp sites. These coregulators affect Crp binding, either by modifying the local DNA conformation or by increasing the local Crp concentration through direct protein-protein contacts [
23,
38,
39]. In the case of P
fucAO, the binding of FucR likely facilitates the binding of Crp to its sites, which in turn recruits RNA polymerase to the promoter region. Without FucR bound to the nearby upstream region, Crp appears to occupy its sites less efficiently, probably due to the presence of a local DNA structure. Alternatively, DNA-bound FucR might recruit Crp to P
fucAO by direct binding.
Based on these observations, we propose a modulation mechanism as follows: Crp-cAMP is the deterministic regulator, dictating the expression of the fucAO operon under both noninducing and inducing conditions. In the absence of fucose, FucR is scarce and has no DNA binding capability due to the lack of the cofactor, fuculose-1-P. In this case, Crp inefficiently binds to PfucAO due to a local DNA conformation and maintains operon transcription at a basal level. In the presence of fucose, FucR is abundant and activated. When bound to the DNA, FucR facilitates Crp binding to PfucAO via alteration of the local DNA conformation or direct protein-protein interactions, which in turn recruits RNAP to PfucAO to initiate transcription.
Our work showed that Crp binding to the upstream O
Crp2 site was vital for
fucAO transcription, as mutations of this site abolished operon expression. As shown in
Figure 4B, a second binding site, O
Crp3, is present downstream of P
fucAO. When this site was mutated, operon expression only slightly decreased, by about 30%. These results indicate that this downstream binding site is not essential for operon transcription, but simultaneous bindings of Crp to both sites are required for maximal transcription. In addition, we showed that Crp binding to this downstream site alone (in the absence of the upstream site) did not affect operon activity, suggesting that this downstream site only plays an accessory role and that its function depends on Crp binding to the upstream site. Another possibility is that Crp is incapable of binding to O
Crp3 in the absence of Crp bound to the upstream site, probably due to an intrinsic DNA structure. It is unknown why Crp can promote
fucAO expression by binding to a downstream site and how Crp maximizes operon expression by binding to these two sites flanking P
fucAO. In some cases, Crp is able to activate promoters by binding to a downstream 5′UTR region [
38,
40,
41]. Similarly, several other global transcriptional factors, such as ArcA and SoxR, have been reported to activate gene expression by binding to one or more regions downstream of their promoters [
42,
43]. Alternatively, Crp binding to O
Crp3 located at 5′UTR might have enhanced the mRNA stability, thereby increasing translation efficiency.
Two FucR binding sites were identified and functionally validated in this study. The second site, O
FucR3, is critical, as the loss of this site terminates FucR-mediated induction of the
fucAO operon. The first site, O
FucR2, located upstream of O
FucR3, plays a secondary role in operon induction, as its mutation only leads to a 30% reduction in operon expression. As shown in
Figure 4B, O
FucR3 is adjacent to the upstream Crp binding site O
Crp2, while O
FucR2 is far away. Conceivably bound to O
FucR3, FucR more readily recruits Crp to P
fucAO. Simultaneous bindings of either FucR or Crp to their two sites in P
fucAO are needed in order to further promote operon transcription.
Our study revealed that the same
fucAO promoter was significantly more active at the
lac locus than its native locus under both noninducing and inducing conditions. Similar observations were made when using the promoter P
fucO (a weak native promoter) and the promoter P
tet (a strong constitutive promoter). Genes near the origin of replication (
oriC) generally have higher expression levels due to increased dosages [
44,
45,
46]. However, the different activities for P
fucAO appear not to be due to the distance of these two loci from the
oriC (
Figure 5). The
E. coli nucleoid is highly compact, and its organization is mediated by DNA supercoiling, macromolecular abundance, and six major nucleoid-associated proteins (NAPs), leading to the formation of multiple topologically isolated loops [
47,
48,
49,
50]. Vora et al. reported the presence of transcriptionally silent domains distributed across the chromosome, and these domains overlap with the genomic regions densely bound by NAPs [
49]. Furthermore, gene silencing within these regions is predominantly attributed to the abnormally low levels of transcription mediated by DNA structuring proteins (that is, not due to weak promoters) [
51]. The
fucAO operon may be situated within such a transcriptionally silent chromosomal domain. As a major NAP, H-NS has been reported to impede
fucAO operon expression [
52]. H-NS preferentially binds to AT-rich DNA regions. The strong repression might be attributed to the direct binding of H-NS to the
fucAO regulatory region, which is highly A/T rich (64.3% AT content for the
fucPIK/
fucAO intergenic region and 67.5% for the
fucAO regulatory region from −276 to −34 with respect to +1). H-NS exerts its repressive effect on transcription by reinforcing supercoiled structures of local chromosomal DNA by simultaneously binding to two or multiple target sites and subsequently looping them together, thus trapping RNAP at or excluding it from the promoter [
27,
53,
54,
55]. This could be the case for H-NS repression of the
fucAO operon. More studies are needed to examine how the
fucAO locus is transcriptionally silenced.
In conclusion, we have provided a detailed study on transcriptional regulation of the fucAO operon by identifying and validating the true primary promoter and the binding sites for two major activators, Crp and FucR. Operon expression is exclusively dependent on Crp, while FucR, once activated and bound to DNA, appears to favor the binding of Crp to the promoter, thus recruiting RNA polymerase to initiate transcription. Further studies are needed to answer why Crp must bind to both upstream and downstream sites to maximize operon expression, to see if Crp binding to the downstream OCrp3 site promotes mRNA stability, and to examine the molecular mechanisms by which Crp and FucR coordinate each other’s effects in activating the fucAO promoter. Furthermore, it will be of interest to investigate how the fucAO operon is silenced at its native locus since the promoter is more active at another chromosomal location.
4. Materials and Methods
4.1. E. coli Strains and Growth Conditions
Bacterial strains and plasmids used in this study are described in
Supplementary Table S1. All test strains were derived from
E. coli K12 strain BW25113 [
56]. Using the Lambda-Red recombination system [
56], the chromosomal region carrying the
lacI,
lacZ, and
lacY genes was first replaced by a kanamycin marker (
kmr) that was subsequently flipped out by pCP20, yielding strain ZZ200. Similarly, the
fucR gene and the
srsR gene were deleted from ZZ200, yielding strains ZZ201 and ΔZZ202, respectively. The
lacIZY mutation was transferred to strain Δ
crp Glp
+ (able to utilize glycerol) [
57], yielding strain ZZ203. The primers used in this study are listed in
Supplementary Table S2.
To genetically modify E. coli strains, they were routinely cultured in LB media with one or two appropriate antibiotics at 30 °C or 37 °C. To measure the fucAO promoter or operon activities, test strains were cultured in M63 minimal media with either 0.5% (w/v) glycerol or 0.5% (w/v) L-fucose as the carbon source. The 10× M63 salt solution contains 15 mM (NH4)2SO4, 100 mM KH2PO4, and 0.02 mM FeSO4·7H2O. After diluting to 1× M63 medium, it was supplemented with 10−4% thiamine (w/v) and 1.7 mM MgSO4. When necessary, ampicillin, kanamycin, and chloramphenicol were added to the media at 100 μg/mL, 25 μg/mL, and 10 μg/mL, respectively.
4.2. Construction of the fucAO Operon Transcriptional LacZ Reporter at the fuc Locus
The
lacZ structural gene plus its upstream ribosome binding site (RBS), which is CACAGGAAACAGCT, was amplified from the genomic DNA of strain MG1655. A
cat gene (encoding chloramphenicol resistance) with its constitutive promoter (P
cat) was amplified from pZA31 [
58]. Using fusion PCR, these two fragments were combined by fusing the 3′ end of
lacZ to the 5′ end of P
cat, yielding a fusion fragment “
lacZ:
cat” (note:
lacZ has its own RBS and
cat has its own promoter). Using the Lambda-Red system, the “
lacZ:
cat” cassette was chromosomally integrated downstream of
fucO in strain ZZ200 to substitute for a 15-bp region (tgatgtgataatgcc) between the 5th and the 22nd nucleotides relative to the
fucO stop codon. This yielded the transcriptional reporter strain ZZ204, in which
fucA,
fucO, and
lacZ form an operon driven by the
fucAO operon promoter (P
fucAO) upstream of the
fucA gene. In addition, among this “
fucA:
fucO:
lacZ” operon reporter, genes
fucO and
lacZ are driven by the
fucO promoter (P
fucO) located in the 3′ end of
fucA [
18] as well (
Figure 2A). As expected, the reporter strain remains fucose-positive (Fuc
+) since the
fuc regulon was unchanged.
To test the dependence of
fucAO expression on Crp, FucR, and SrsR, the
fucAO transcriptional operon reporter was individually transferred to deletion mutants Δ
crp Glp
+ [
57], Δ
fucR, and Δ
srsR, yielding strains ZZ205, ZZ206, and ZZ207, respectively.
4.3. Construction of Chromosomal Promoter-LacZ Reporters at the fuc Locus
To determine the activity of the main promoter (P
fucAO) driving expression of the
fucAO operon, the “
lacZ:
cat” cassette (note:
lacZ has its own RBS) was moved immediately downstream of the 10th codon of
fucA (referred to as
fucA’) while the remaining part of
fucAO was deleted. A stop codon, TAA, was introduced between
fucA’ and
lacZ. This yielded strain ZZ208, in which
fucA’ and
lacZ form an operon driven by P
fucAO alone at the native
fuc locus (
Figure 3A).
To test the activity of P
fucO alone, a
rrnB terminator (T1) was inserted between P
fucAO and
fucA. Briefly, the region for
kmr and T1 was amplified from plasmid pKDT [
26]. The PCR products were gel purified and subsequently integrated immediately upstream of the beginning of
fucA in strain ZZ204. The
kmr gene was flipped out, yielding strain ZZ209, in which
fucO and
lacZ are driven only by P
fucO since P
fucAO is blocked by the
rrnB terminator T1 (
Figure 3B).
To see if the proposed
fucAO promoter P
fucAO.hc is active, the same “
lacZ:
cat” cassette was substituted for the region of −147 to +2372 with respect to the
fucA start site, including most parts of the 5′UTR and the entire
fucAO operon. This yielded strain ZZ210, in which P
fucAO.hc alone drives
lacZ at the
fuc locus (
Figure 3C). It is worthwhile to note that these three promoter
lacZ reporters are Fuc
− due to the lack of the
fucAO operon.
4.4. Construction of Chromosomal Promoter-LacZ Reporters at the lac Locus
To further characterize these promoters, the same three promoter
lacZ transcriptional reporters described in
Section 4.3 were individually moved to the
lac locus while leaving the native
fuc regulon intact. With these strains, promoter activities can be examined under both noninducing and inducing conditions. To construct P
fucAO driving
lacZ at the
lac locus, the cassette “P
fucAO-
fucA’-lacZ” shown in
Figure 3A was moved to the
lac locus. Briefly, the entire
fucPIK/
fucAO intergenic region plus the first 10 codons of
fucA (that is, −546 to +30 with respect to the
fucA start site) followed by a stop codon was cloned into pKDT, yielding pKDT-P
fucAO (
Table S1). The “
kmr:T:P
fucAO” cassette (containing the first 10
fucA codons and a stop codon) was integrated upstream of the 14th nucleotide with respect to the
lacZ translational start site in strain MG1655 deleted for
lacY [
59], replacing the
lacI gene and the
lacZ promoter. The reporter was transferred to BW25113, yielding strain ZZ211, in which P
fucAO alone drives
lacZ transcription at the
lac locus while the native
fuc regulon is unchanged (
Figure 5A).
Similarly, seven shorter promoter versions (−480 to +30, −377 to +30, −339 to +30, −270 to +30, −206 to +30, −166 to +30, and −123 to +30 relative to the
fucA start site) with various truncations from the 5′ end of P
fucAO were individually substituted for P
fucAO in the P
fucAO-
lacZ reporter cassette at the
lac locus, yielding strains ZZ212, ZZ213, ZZ214, ZZ215, ZZ216, ZZ217, and ZZ218, respectively. These resultant strains harbor promoters P
AO.V2, P
AO.V3, P
AO.V4, P
AO.V5, P
AO.V6, P
AO.V7, and P
AO.V8 that individually drive
lacZ at the
lac locus (
Figure 6A,B).
To construct P
fucO driving
lacZ at the
lac locus, the region of −449 to +30 with respect to the
fucA start site (carrying P
fucO and the first 10 codons of
fucO followed by a stop codon) was cloned into pKDT, yielding pKDT_P
fucO (
Table S1). The “
kmr:T:P
fucO” cassette was inserted into the same position as ZZ211 in strain MG1655Δ
lacY and subsequently transferred to BW25113, yielding strain ZZ219, in which P
fucO alone drives
lacZ transcription at the
lac locus (
Figure 3E).
To construct PfucAO.hc driving lacZ at the lac locus, the region from −546 to −147 relative to the fucA translational site was amplified from pKDT_PfucAO and then inserted into the same lac position as for PfucAO in ZZ211. The reporter was transferred to BW25113, yielding strain ZZ220, in which PfucAO.hc alone drives lacZ at the lac locus.
4.5. Determining Transcriptional Start Sites Using SMARTer® RACE 5′/3′ Kit
To prepare total RNA, strain BW25113 was shaken at 37 °C in M63 minimal media with 0.5% fucose as the sole carbon source. At OD600 of about 1.0, a 600 μL culture was vortexed with 1.2 mL RNAprotectTM Bacteria Reagent (Qiagen, Hilden, Germany) in a 2.0 mL microcentrifuge tube. After 5 min of incubation at room temperature, the mixture was centrifuged at 5000 rpm for 10 min, and the pellet was air dried for 5 min before being frozen at −20 °C. A NucleoSpin® RNA Kit (Takara Bio, San Jose, USA) was used to extract total RNA from the frozen cell pellet. The pellet was first lysed with lysozyme (1 mg/mL) and subsequently bound to the NucleoSpin Filter. The NucleoSpin filter was desalted, treated with the provided rDNase (to remove residual DNA), washed, and dried prior to RNA elution with RNase-free deionized water. The eluted total RNA samples were stored at −80 °C, and the absorbance ratios 260/280 and 260/230 of the eluted RNA samples were measured using a NanoDrop 1000 (Thermo Fisher, Waltham, USA) to ensure RNA purity.
mRNA was extracted using a MICROBExpressTM Bacterial mRNA Purification Kit (Invitrogen). The total RNA sample was thawed slowly on ice, mixed with 100% ethanol, and centrifuged (12,000 rpm for 30 min) at 4 °C. The resulting RNA pellet was washed three times using 70% ethanol, air dried, and dissolved in 15 μL TE buffer (containing 10 mM Tris-HCl and 1 mM EDTA at pH 8.0). RNA was then introduced to the provided binding buffer with Capture Oligo Mix. The mixture was incubated at 70 °C for 10 min and 37 °C for 30 min to denature the 16S and 23S rRNAs and facilitate hybridization of the rRNAs to capture oligonucleotides. The mixture was combined with the MagBeads and incubated for 15 min at 37 °C to allow the MagBeads to anneal to the hybridized oligonucleotides bound to the rRNA. The MagBead slurry was then placed in a magnetic stand to draw the MagBeads from the solution, leaving supernatant. The mRNA present in the supernatant was precipitated using 5 mg/mL glycogen, 3M sodium acetate, and 100% ethanol. After centrifugation (13 K rpm, 30 min), the mRNA pellet was washed (with 70% ethanol), air dried briefly, and dissolved in nuclease-free deionized water. The concentration and purity of the mRNA samples were determined by measuring their absorbance ratios 260/280 and 260/230 before storing them at −80 °C.
5′RACE was performed using the SMARTer
® RACE 5′/3′ kit (Takara Bio USA). First, to synthesize first-strand cDNA, the extracted mRNA sample was combined with a random hexamer mixture that binds to the mRNA. The mixture was incubated at 72 °C for 3 min and then 42 °C for 2 min. A buffer containing RNase inhibitor, Reverse Transcriptase, and SMARTer II Oligonucleotide (all provided) was added to the mixture which was subsequently incubated at 42 °C for 90 min and then 70 °C for 10 min. The resulting mixture (first-strand cDNA) was diluted with tricine-EDTA buffer. After dilution, the first-strand cDNA was combined with a PCR master mix, 5′ gene-specific primer (that is, GSP-fucA-R) (
Table S2), and the universal primer mix for amplification. PCR products (that is, amplified cDNA) were purified by gel electrophoresis, and the purified cDNA was subsequently submitted for sequencing. The first nucleotide immediately downstream of the SMARTer II Oligonucleotide sequence is the transcriptional start site (+1) of the target gene.
4.6. Alteration of Crp and FucR Binding Sites within the fucAO Regulatory Region
Crp and FucR are the primary regulators activating
fucAO operon expression. There are two Crp binding sites (O
Crp2 and O
Crp3) and two FucR binding sites (O
FucR2 and O
FucR3) identified within the
fucAO regulatory region (
Figure 4B and
Figure 6A). Thus far, these binding sites have not been validated. The “P
AO.V5-
lacZ” reporter cassette harbored in strain ZZ214 was employed for examining the functions of these binding sites, as the promoter P
AO.V5 carries all the binding sites and has full promoter activity under both noninducing and inducing conditions. Fusion PCR was used to mutate these sites by changing some key nucleotides within the binding motifs. P
AO.V5 was divided into two separate fragments with a short (about 30 bp) overlapped region in between. The nucleotides to be altered were included in the overlapped region. These two fragments were ligated by fusion PCR, yielding a fusion product with the desired altered nucleotides on the binding sites.
The consensus sequence for Crp binding sites is “aaaTGTGAtctagaTCACAttt” (two binding motifs are in bold and capitalized). To mutate OCrp2 with the sequence “ttagtTGAaccaggTCACAaaa” (the motif nucleotides matching the consensus ones are capitalized), 8 nucleotides within two binding motifs were replaced by other nucleotides, resulting in the sequence “ttagtctaaccaggcgctgaaa” (the altered bases are underlined). To mutate OCrp3, its sequence “tagTGTGAaaggaacaACAtta” was changed to “taggcctcaaggaacagattta,” in which 8 nucleotides were altered. These two modified PAO.V5 versions with mutated OCrp2 and OCrp3 were substituted for PAO.V5, first in plasmid pKDT-PAO.V5 and then in strain ZZ215, yielding strains ZZ221 and ZZ222, in which lacZ is exclusively driven by PAO.V5 with mutated OCrp2 (for ZZ221) or OCrp3 (for ZZ222).
The proposed binding motif for FucR has the consensus sequence “G(A)C(T)C(G)A(C)A(G)A(TC)A(T)
CGGT(G)
CAT(A)T(CG)”, where the bold nucleotides CGG and CA are most conserved [
24]. Based on this consensus sequence, two FucR binding sites (O
FucR2 and O
FucR3) were identified with respective sequences as “ccgaaaaCGGtCAtt” and “ttaagagCGGtCAtt” (
Figure 4B). Using the same strategy as above, these binding sites were altered by respectively changing their sequences to ccgaaa
cgttt
gctt and ttaagag
gttcgctt (the altered nucleotides are underlined) in P
AO.V5. These modified P
AO.V5 with the mutated FucR binding sites were substituted for P
AO.V5 in strain ZZ215, yielding strains ZZ223 and ZZ224, in which
lacZ is exclusively driven by P
AO.V5 with mutated O
FucR2 (for ZZ223) or O
FucR3 (for ZZ224).
4.7. β-Galactosidase (LacZ) Activity Assay
To prepare samples for β-galactosidase (LacZ) assay, a fresh colony from the reporter strain of interest was cultured in 5 mL of LB media at 37 °C with shaking for about 6 h. 30 μL of the culture was transferred to another tube containing 3 mL of collection media. In this study, the collection media used were M63 minimal media with 0.5% glycerol (noninducing conditions) and M63 minimal media with 0.5% fucose (inducing conditions). The M63 culture was then left to grow overnight at 37 °C with shaking. The next day, a specific amount of overnight culture (preculture) was inoculated into 5 mL of the same collection medium to OD600 of 0.02, and the new culture was grown at 37 °C with shaking. During the exponential growth phase, at least four samples were collected at OD600 between 0.2 and 1.0. Collected samples were immediately frozen at −20 °C prior to the assay.
To measure the β-galactosidase (LacZ) activities, the previously collected samples were first thawed to room temperature. Then 200 μL of sample, 800 μL of Z-Buffer, and 25 μL of chloroform were combined in a small glass tube and vortexed twice at 10 s each. The sample tubes were placed into a water bath incubator and warmed to 37 °C. To initiate the reaction, 200 μL of prewarmed o-nitrophenyl-β-D-galactopyranoside (β-ONPG) at 4 mg/mL was added to each sample. After a yellow color was visibly developed, 0.5 mL of 1M sodium carbonate was added to each sample and vortexed to stop the reaction. The reaction mixture was appropriately diluted and then centrifuged for 2.5 min at 15,000 rpm. Absorbance values of the prepared reaction mixtures were measured at 420 nm and 550 nm. The β-galactosidase activity (Miller units) for each sample was then calculated using the formula: [1000 × (OD
420 − 1.75 × OD
550) x Dilution factor]/[Time of reaction (min) × Volume of sample (mL)] [
60]. The slope of LacZ activities in Miller units versus ≥4 collected OD
600 values represented the reporter strain activity. The final β-galactosidase activity for each strain was the average of at least three repeats (that is, at least 12 samples per strain).
4.8. Growth Rate Measurement
One fresh colony of the test strain was cultured in LB with shaking for 8 h. 20 μL of the culture was transferred to 3 mL M63 minimal medium with 0.5% fucose. After overnight growth with shaking at 37 °C, an appropriate amount of the culture was inoculated into 5 mL of the same M63 + fucose medium within a glass tube at the initial OD600 of 0.01. The tube was shaken (250 rpm) at 37 °C. In the range of OD600 from 0.1 to 1, five or more samples were taken at various time intervals for OD600 measurements. The slope of OD600 in log values versus time (minutes) represents the growth rate (that is, time per doubling).
4.9. Statistical Analysis
All β-galactosidase activity data are expressed as mean
± standard deviation (SD). Statistical significance was tested by either two-sample
t-test (for 2 treatments) or 1-way ANOVA followed by Tukey Kramer’s post hoc test (for ≥3 treatments). All figures and β-galactosidase activities were generated using Microsoft Excel (Version 16.66.1) or RStudio (Version 2023.12.0 + 369 “Ocean Storm” Release for Windows). Details of the statistical tests used are indicated in the figure legends. Sample size details are described in
Section 4.7 and the legend of
Figure 2. Between each of two treatments shown in figures dealing with
≥3 treatments, different lowercase letters marked above the bar graphs represent statistically significant differences at
p-values < 0.05, while the same letters represent no significant differences at
p-values > 0.05.